Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging

被引:11
|
作者
Portero-Otin, Manuel [1 ]
de la Maza, M. Pia [2 ]
Uribarri, Jaime [3 ]
机构
[1] Univ Lleida, Fac Med, Dept Med Expt, Lleida 25196, Spain
[2] Univ Desarrollo, Dept Med, Clin Alemana, Ctr Nutr & Diabet, Santiago 7610658, Chile
[3] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10021 USA
关键词
insulin resistance; glycation; oxidative stress; inflammation; ultraprocessed foods; METABOLIC SYNDROME; GUT MICROBIOTA; DIABETES-MELLITUS; OXIDATIVE STRESS; AGE RESTRICTION; SENSITIVITY; RECEPTOR; INFLAMMATION; GLUCOSE; OBESITY;
D O I
10.3390/cells12131684
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Insulin resistance (IR) is commonly observed during aging and is at the root of many of the chronic nontransmissible diseases experienced as people grow older. Many factors may play a role in causing IR, but diet is undoubtedly an important one. Whether it is total caloric intake or specific components of the diet, the factors responsible remain to be confirmed. Of the many dietary influences that may play a role in aging-related decreased insulin sensitivity, advanced glycation end products (AGEs) appear particularly important. Herein, we have reviewed in detail in vitro, animal, and human evidence linking dietary AGEs contributing to the bodily burden of AGEs with the development of IR. We conclude that numerous small clinical trials assessing the effect of dietary AGE intake in combination with strong evidence in many animal studies strongly suggest that reducing dietary AGE intake is associated with improved IR in a variety of disease conditions. Reducing AGE content of common foods by simple changes in culinary techniques is a feasible, safe, and easily applicable intervention in both health and disease. Large-scale clinical trials are still needed to provide broader evidence for the deleterious role of dietary AGEs in chronic disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Evaluation of the effects of dietary advanced glycation end products on inflammation
    Demirer, Busra
    Fisunoglu, Mehmet
    NUTRITION BULLETIN, 2024, 49 (01) : 6 - 18
  • [32] Effect of dietary advanced glycation end products on mouse liver
    Patel, Raza A.
    Baker, Susan S.
    Liu, Wensheng
    Desai, Sonal
    Alkhouri, Razan
    Kozielski, Rafal
    Mastrandrea, Lucy
    Sarfraz, Adil
    Cai, Weijing
    Vlassara, Helen
    Patel, Mulchand S.
    Baker, Robert D.
    Zhu, Lixin
    FASEB JOURNAL, 2012, 26
  • [33] A Role for Advanced Glycation End Products in Molecular Ageing
    Zgutka, Katarzyna
    Tkacz, Marta
    Tomasiak, Patrycja
    Tarnowski, Maciej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [34] Role of advanced glycation end products in cardiovascular disease
    Hegab, Zeinab
    Gibbons, Stephen
    Neyses, Ludwig
    Mamas, Mamas A.
    WORLD JOURNAL OF CARDIOLOGY, 2012, 4 (04): : 90 - 102
  • [35] The role of advanced glycation end products in the development of atherosclerosis
    Peppa M.
    Uribarri J.
    Vlassara H.
    Current Diabetes Reports, 2004, 4 (1) : 31 - 36
  • [36] Role of advanced glycation end products in diabetic nephropathy
    Forbes, JM
    Cooper, ME
    Oldfield, MD
    Thomas, MC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : S254 - S258
  • [37] The role of advanced glycation end products and their mechanism in DN
    李奕茜
    王洋
    方朝晖
    马建
    World Journal of Integrated Traditional and Western Medicine, 2017, 3 (03) : 8 - 11
  • [38] Role of advanced glycation end products in cellular signaling
    Ott, Christiane
    Jacobs, Kathleen
    Haucke, Elisa
    Santos, Anne Navarrete
    Grune, Tilman
    Simm, Andreas
    REDOX BIOLOGY, 2014, 2 : 411 - 429
  • [39] Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis
    Röcken, C
    Kientsch-Engel, R
    Mansfeld, S
    Stix, B
    Stubenrauch, K
    Weigle, B
    Bühling, F
    Schwan, M
    Saeger, W
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04): : 1213 - 1220
  • [40] Role of advanced glycation end products in diabetic neuropathy
    Sugimoto, Kazuhiro
    Yasujima, Minoru
    Yagihashi, Soroku
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) : 953 - 961